Laboratory Animal Models, 3D Cultures and Organoids

Chapter 1 Introduction

• Background
• Study Goals and Objectives
• Reasons for Doing This Study
• Scope of Report
• Information Sources and Methodology
• Geographic Breakdown
• Analyst's Credentials
• Custom Research
• Related Reports

Chapter 2 Summary and Highlights

• Laboratory Animal Models
• 3D Cell Cultures

Chapter 3 Animal Model Market Technology Background

• Methods of Animal Model and 3D Cell Culture Modification
• Physical and Chemical Mutations
• Targeted Mutations
• Laboratory Animal Models
• Market Definition
• Animal Model Lines
• Common Species of Laboratory Animals
• Current Trends in Animal Model Usage

Chapter 4 3D Cell Cultures Market Breakdown by Technology

• 3D Cell Cultures
• Spheroids
• 3D Cultures vs. 2D Cultures vs. 2.5D Cultures
• Scaffold-Based and Scaffold-Free 3D Cell Cultures
• Scaffold-Free 3D Cell Cultures
• Scaffold-Based 3D Cell Cultures
• Tissue Engineering and Bioprinting
• 3D Bioprinting Technology
• Microfluidic Organ-on-Chip Platforms
• Types of Organ-on-Chip Devices

Chapter 5 Organoids Market Breakdown by Technology

• Organoids
• Introduction
• Organoids Technology and Principles
• Organoid Technology Timeline
• Types of Organoids
• Organoid Biobanking and Libraries
• Organoid System Complexity

Chapter 6 Market Breakdown by End User

• Animal Models by End User
• Academia and Research Institutions
• Biomedical and Pharmaceutical Companies
• Regulatory Processes and Routine Production
• Cosmetics Industry
• 3D Cell Cultures by End User
• Basic Research
• Biomedical and Pharma Companies
• Regulatory Processes and Routine Production
• Cosmetics Industry

Chapter 7 Market Breakdown by Application

• Drug Discovery, Cancer Research, and Personalized Medicine
• Drug Discovery and High-throughput Compound Screening
• Cancer Research
• Personalized Medicine
• Regenerative Medicine and Transplantations
• Toxicity and Safety Testing
• Drug Toxicity Testing

Chapter 8 Market Breakdown by Region

• Asia-Pacific (APAC)
• Australia
• China
• Japan
• North America
• The U.S.
• Canada
• Mexico
• Europe
• Great Britain
• Germany
• France
• Rest of Europe
• The Middle East and Africa (MEA)
• Israel
• South America
• Brazil

Chapter 9 Patent Review/New Developments

Chapter 10 Analysis of Market Opportunities

• Market Opportunities: Animal Models
• Market Opportunities: 3D Cell Culture Segment
• Organs-on-Chip
• Organoids
• Bioprinting
• Advantages and Disadvantages of 3D Cell Cultures and Animal Models
• Animal Models
• 3D Cell Cultures in General
• Organoids
• Organs-on-Chip

Chapter 11 Profiles of Companies and Important Institutions

• Animal Model Companies
• Alphagenesis Inc.
• Charles River Laboratories International Inc.
• Covance Inc.
• Crown Bioscience Inc.
• Envigo
• Genoway S.A.
• Jackson Laboratory
• Janvier Labs
• Oak Hill Genetics
• Primgen
• Taconic Biosciences
• Transgenic Inc.
• Transposagen Biopharmaceuticals Inc.
• Bioprinting And Regenerative Medicine Companies
• Allevi
• Aspect Biosystems Ltd.
• Bioink Solutions Inc.
• Cellink Inc.
• Collplant Holdings Ltd.
• East River Biosolutions/Xylyx Bio
• Epibone
• Mattek Corp.
• Nano 3D Biosciences Inc.
• Organovo Holdings Inc.
• Pepgel LLC
• Regenhu
• Tevido Biodevices Inc.
• Tissuse Gmbh
• Organ-On-Chip Companies
• Axosim
• Emulate, Inc.
• Kirkstall Ltd.
• Micronit Microtechnologies
• Mimetas
• Tara Biosystems Inc.
• Organoid Companies
• 3Dnamics
• Cellesce
• Cincinnati Children’s Hospital Medical Center
• Hubrecht Organoid Technology
• Qgel
• R&D Systems Inc.
• Stemcell Technologies Inc.
• Trevigen Inc.
• Other 3D Cell Culture Companies
• 3D Biotek Llc
• Advanced Biomatrix Inc.
• Horizon Discovery Group Plc
• In Sphero Inc.
• Merck & Co., Inc.
• Promocell Gmbh
• Reprocell Inc.
• Synthecon, Inc.

List of Tables
Summary Table A: Global Market for Laboratory Animal Models, by Type, Through 2023
Summary Table B: Global Market for Organs-on-Chips and Organoids, Through 2023
Table 1: Global Market for Laboratory Mice, by Region, Through 2023
Table 2: Global Market for Laboratory Rats, by Region, Through 2023
Table 3: Global Market for Laboratory Guinea Pigs, by Region, Through 2023
Table 4: Global Market for Laboratory Rabbits, by Region, Through 2023
Table 5: Global Market for Laboratory Hamsters, by Region, Through 2023
Table 6: Global Market for Laboratory Cats, by Region, Through 2023
Table 7: Global Market for Laboratory Dogs, by Region, Through 2023
Table 8: Global Market for Laboratory Pigs, by Region, Through 2023
Table 9: Global Market for Laboratory Nonhuman Primates, by Region, Through 2023
Table 10: Tissue Engineering Related Search Terms in PubMed, Through 2018
Table 11: Tissue Bioprinting Related Search Terms in PubMed, Through 2018
Table 12: Organ-on-Chip Related Search Terms in PubMed, Through 2018
Table 13: Investments in Organ-on-Chip Technology, by Company, Through 2018
Table 14: Global Market for Organs-on-Chips, Through 2023
Table 15: Organoid Types Mentioned in PubMed Articles, Through 2018
Table 16: Mentions of Spheroids in PubMed Articles, Through 2018
Table 17: Organoid Centers
Table 18: Global Market for Organoids, by Type, Through 2023
Table 19: Global Market for Animal Models, by End User, Through 2023
Table 20: Continents Banning Animal Testing for Cosmetics, by Country and Year Banned, 2013-2019
Table 21: Asia-Pacific Market for Laboratory Animal Models, by Type, Through 2023
Table 22: Australian Market for Laboratory Animal Models, by Type, Through 2023
Table 23: Chinese Market for Laboratory Animal Models, by Type, Through 2023
Table 24: Japanese Market for Laboratory Animal Models, by Type, Through 2023
Table 25: North American Market for Laboratory Animal Models, by Type, Through 2023
Table 26: U.S. Market for Laboratory Animal Models, by Type, Through 2023
Table 27: Canadian Market for Laboratory Animal Models, by Type, Through 2023
Table 28: Mexican Market for Laboratory Animal Models, by Type, Through 2023
Table 29: European Market for Laboratory Animal Models, by Type, Through 2023
Table 30: Great Britain Market for Laboratory Animal Models, by Type, Through 2023
Table 31: German Market for Laboratory Animal Models, by Type, Through 2023
Table 32: French Market for Laboratory Animal Models, by Type, Through 2023
Table 33: Rest of European Market for Laboratory Animal Models, by Type, Through 2023
Table 34: Middle Eastern and African Market for Laboratory Animal Models, by Type, Through 2023
Table 35: Israeli Market for Laboratory Animal Models, by Type, Through 2023
Table 36: South American Market for Laboratory Animal Models, by Type, Through 2023
Table 37: Brazilian Market for Laboratory Animal Models, by Type, Through 2023
Table 38: Review of Selected Patents and Patent Applications on Laboratory Animal Models, 2006-2018
Table 39: Global Number of Transplanted Organs, by Country, 2017
Table 40: Charles River Laboratories: Segments
Table 41: Charles River Laboratories: Revenue, 2013-2017
Table 42: Charles River Laboratories: RMS Company Yearly Revenues/Operating Income, by Quarter, 2016 and 2017
Table 43: Charles River Laboratories: Company Business Structure Data, by Segment, 2017
Table 44: Crown Bioscience Inc.: Segments
Table 45: Envigo: Segments
Table 46: Envigo: Consolidated Revenue, by Segment, 2015-2018
Table 47: Envigo: RMS Quarterly Revenue, 2015-2018
Table 48: Envigo: Types of Laboratory Animals
Table 49: Genoway S.A.: Segments
Table 50: Genoway S.A.: Sales, 2016 and 2017
Table 51: Jackson Laboratory: Segments
Table 52: Jackson Laboratory: Company Data, 2013-2016
Table 53: Janvier Labs: Segments
Table 54: Taconic Biosciences: Segments
Table 55: Transgenic Inc.: Segments
Table 56: Transgenic Inc.: Company Data, 2014-2018
Table 57: Transposagen Biopharmaceuticals Inc.: Segments
Table 58: Organovo: Expenses on R&D, 2013-2018
Table 59: 3D Biotek LLC: Segments
Table 60: In Sphero Inc.: Segments
Table 61: Merck & Co., Inc.: Revenue, by Region
Table 62: Merck & Co., Inc.: Company Data, 2013-2017
Table 63: Reprocell Inc.: Acquisitions

List of Figures
Summary Figure A: Global Market for Laboratory Animal Models, by Type, 2016-2023
Summary Figure B: Global Market for Organ-on-Chip and Organoids, 2017-2023
Figure 1: PubMed Timeline for the Mesh Terms of Types of Mice, 2000-2017
Figure 2: Global Market for Laboratory Mice, by Region, 2016-2023
Figure 3: PubMed Timeline for the Mesh Terms of Types of Rats, 2000-2017
Figure 4: Global Market for Laboratory Rats, by Region, 2016-2023
Figure 5: Global Market for Laboratory Guinea Pigs, by Region, 2016-2023
Figure 6: Global Market for Laboratory Rabbits, by Region, 2016-2023
Figure 7: Global Market for Laboratory Hamster, by Region, 2016-2023
Figure 8: Global Market for Laboratory Cats, by Region, 2016-2023
Figure 9: Global Market for Laboratory Dogs, by Region, 2016-2023
Figure 10: Global Market for Laboratory Pigs, by Region, 2016-2023
Figure 11: Global Market for Laboratory Nonhuman Primates, by Region, 2016-2023
Figure 12: Tissue Engineering Related Search Terms in PubMed, 2010-2018
Figure 13: Tissue Bioprinting Related Search Terms in PubMed, 2010-2018
Figure 14: Timeline for Possible Availability of 3D Printed Organs and Tissues for Humans, 2018-2043
Figure 15: Organ-on-Chip Related Search Terms in PubMed, 2010-2018
Figure 16: Investments in Organ-on-Chip Technology, by Company, 2008-2018
Figure 17: Global Market for Organs-on-Chips, 2017-2023
Figure 18: Timeline for Possible Availability of Organ-on-Chip Devices for Drug Screening in Human Patients, 2018-2030
Figure 19: Organoid Types Mentioned in PubMed Articles, 2010-2018
Figure 20: Mentions of Spheroids in PubMed Articles, 2010-2018
Figure 21: Global Market for Organoids, by Type, 2017-2023
Figure 22: Global Market for Animal Models, by End User, 2016-2023
Figure 23: Asia-Pacific Market for Laboratory Animal Models, by Type, 2016-2023
Figure 24: Australian Market for Laboratory Animal Models, by Type, 2016-2023
Figure 25: Chinese Market for Laboratory Animal Models, by Type, 2016-2023
Figure 26: Japanese Market for Laboratory Animal Models, by Type, 2016-2023
Figure 27: North American Market for Laboratory Animal Models, by Type, 2016-2023
Figure 28: U.S. Market for Laboratory Animal Models, by Type, 2016-2023
Figure 29: U.S. National Toxicology Program Funding for Toxicity Testing, 2013-2018
Figure 30: Canadian Market for Laboratory Animal Models, by Type, 2016-2023
Figure 31: Mexican Market for Laboratory Animal Models, by Type, 2016-2023
Figure 32: European Market for Laboratory Animal Models, by Type, 2016-2023
Figure 33: Great Britain Market for Laboratory Animal Models, by Type, 2016-2023
Figure 34: German Market for Laboratory Animal Models, by Type, 2016-2023
Figure 35: French Market for Laboratory Animal Models, by Type, 2016-2023
Figure 36: Rest of European Market for Laboratory Animal Models, by Type, 2016-2023
Figure 37: Middle Eastern and African Market for Laboratory Animal Models, by Type, 2016-2023
Figure 38: Israeli Market for Laboratory Animal Models, by Type, 2016-2023
Figure 39: South American Market for Laboratory Animal Models, by Type, 2016-2023
Figure 40: Brazilian Market for Laboratory Animal Models, by Type, 2016-2023
Figure 41: Global Number of Transplanted Organs, by Country, 2017
Figure 42: Charles River Laboratories: Number of Employees
Figure 43: Charles River Laboratories: RMS Company Yearly Revenues/Operating Income, by Quarter, 2016 and 2017
Figure 44: Charles River Laboratories: Revenue Share, by Segment, 2017
Figure 45: Envigo: Consolidated Revenue, by Segment, 2015-2018
Figure 46: Envigo: RMS Quarterly Revenue, 2015-2018
Figure 47: Merck & Co., Inc.: Revenue, by Region